Lee Jayoung, Kim Shin-Wook, Son Seok Hyun
aDepartment of Radiation Oncology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea bDepartment of Radiation Oncology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Medicine (Baltimore). 2016 Jun;95(26):e4036. doi: 10.1097/MD.0000000000004036.
The purpose of this study was to compare the dosimetric parameters for incidental irradiation to the axilla during whole breast radiotherapy (WBRT) with 3-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT). Twenty left breast cancer patients treated with WBRT after breast-conserving surgery (BCS) were enrolled in this study. Remnant breast tissue, 3 levels of the axilla, heart, and lung were delineated. We used 2 different radiotherapy methods: 3D-CRT with field-in-field technique and 7-field fixed-beam IMRT. The target coverage of IMRT was significantly better than that of 3D-CRT (Dmean: 49.72 ± 0.64 Gy vs 50.24 ± 0.66 Gy, P < 0.001; V45: 93.19 ± 1.40% vs 98.59 ± 0.30%, P < 0.001; V47.5: 86.43 ± 2.72% vs 95.00 ± 0.02%, P < 0.001, for 3D-CRT and IMRT, respectively). In the IMRT plan, a lower dose was delivered to a wider region of the heart and lung. Significantly lower axillary irradiation was shown throughout each level of axilla by IMRT compared to 3D-CRT (Dmean for level I: 42.58 ± 5.31 Gy vs 14.49 ± 6.91 Gy, P < 0.001; Dmean for level II: 26.25 ± 10.43 Gy vs 3.41 ± 3.11 Gy, P < 0.001; Dmean for level III: 6.26 ± 4.69 Gy vs 1.16 ± 0.51 Gy, P < 0.001; Dmean for total axilla: 33.9 ± 6.89 Gy vs 9.96 ± 5.21 Gy, P < 0.001, for 3D-CRT and IMRT, respectively). In conclusion, the incidental dose delivered to the axilla was significantly lower for IMRT compared to 3D-CRT. Therefore, IMRT, which only includes the breast parenchyma, should be cautiously used in patients with limited positive sentinel lymph nodes and who do not undergo complete axillary lymph node dissection.
本研究的目的是比较三维适形放疗(3D-CRT)和调强放疗(IMRT)在全乳放疗(WBRT)期间对腋窝的附带照射剂量学参数。20例保乳手术(BCS)后接受WBRT的左侧乳腺癌患者纳入本研究。勾勒出残留乳腺组织、腋窝的3个层面、心脏和肺。我们使用了2种不同的放疗方法:采用野中野技术的3D-CRT和7野固定束IMRT。IMRT的靶区覆盖明显优于3D-CRT(平均剂量:3D-CRT为49.72±0.64 Gy,IMRT为50.24±0.66 Gy,P<0.001;V45:3D-CRT为93.19±1.40%,IMRT为98.59±0.30%,P<0.001;V47.5:3D-CRT为86.43±2.72%,IMRT为95.00±0.02%,P<0.001)。在IMRT计划中,心脏和肺的更大区域接受的剂量更低。与3D-CRT相比,IMRT在腋窝各层面的附带照射均显著更低(I级平均剂量:3D-CRT为42.58±5.31 Gy,IMRT为14.49±6.91 Gy,P<0.001;II级平均剂量:3D-CRT为26.25±10.43 Gy,IMRT为3.41±3.11 Gy,P<0.001;III级平均剂量:3D-CRT为6.26±4.69 Gy,IMRT为1.16±0.51 Gy,P<0.001;腋窝总平均剂量:3D-CRT为33.9±6.89 Gy,IMRT为9.96±5.21 Gy,P<0.001)。总之,与3D-CRT相比,IMRT对腋窝的附带剂量显著更低。因此,对于前哨淋巴结阳性有限且未进行完整腋窝淋巴结清扫的患者,仅包括乳腺实质的IMRT应谨慎使用。